ACAMPA, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 6.065
NA - Nord America 5.646
AS - Asia 1.045
AF - Africa 57
SA - Sud America 21
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 12.861
Nazione #
US - Stati Uniti d'America 5.618
GB - Regno Unito 1.290
IE - Irlanda 1.032
IT - Italia 948
DE - Germania 721
CN - Cina 608
SE - Svezia 580
RU - Federazione Russa 528
UA - Ucraina 364
FR - Francia 259
SG - Singapore 221
FI - Finlandia 153
VN - Vietnam 91
CI - Costa d'Avorio 48
ES - Italia 38
IN - India 30
BE - Belgio 29
NL - Olanda 26
CZ - Repubblica Ceca 24
GR - Grecia 21
CA - Canada 18
TR - Turchia 17
AU - Australia 16
IR - Iran 16
AT - Austria 12
BR - Brasile 9
CH - Svizzera 7
EU - Europa 7
IL - Israele 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
JP - Giappone 6
BD - Bangladesh 4
ID - Indonesia 4
KG - Kirghizistan 4
LT - Lituania 4
PH - Filippine 4
PK - Pakistan 4
RO - Romania 4
EE - Estonia 3
EG - Egitto 3
HK - Hong Kong 3
KR - Corea 3
LV - Lettonia 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
TH - Thailandia 3
AR - Argentina 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
HR - Croazia 2
MX - Messico 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
PL - Polonia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
VE - Venezuela 1
Totale 12.861
Città #
Southend 1.165
Dublin 999
Fairfield 800
Chandler 478
Santa Clara 444
Ashburn 420
Woodbridge 335
Siena 297
Wilmington 294
Jacksonville 287
Seattle 281
Cambridge 274
Houston 268
Ann Arbor 234
Princeton 178
Menlo Park 173
Singapore 159
Beijing 155
Nanjing 108
Dong Ket 90
Helsinki 88
Boardman 84
Dearborn 82
Vimercate 78
Florence 74
New York 72
Moscow 64
San Diego 63
Milan 55
Shanghai 49
Abidjan 48
Nanchang 46
San Mateo 42
Málaga 33
Mestre 30
Munich 30
Pisa 29
London 28
Brussels 27
Rome 27
Shenyang 25
Jiaxing 21
Chicago 20
Brno 18
Changsha 18
Lancaster 18
Tianjin 18
Livorno 17
Los Angeles 17
Paris 17
San Francisco 17
Washington 17
Lappeenranta 16
Lograto 16
Toronto 16
Jinan 15
Prato 15
Kunming 14
Hebei 13
Norwalk 13
Frankfurt am Main 12
Guangzhou 12
Dallas 11
Hangzhou 11
Izmir 11
Pune 11
Arezzo 10
Columbus 10
Fremont 10
Vienna 10
Ningbo 9
Nuremberg 9
Perugia 8
Taizhou 8
Zanjan 8
Zhengzhou 8
Melbourne 7
Nicola 7
Vicopisano 7
Düsseldorf 6
Hefei 6
Hounslow 6
Hyderabad 6
Petah Tikva 6
Queens 6
Sinalunga 6
São Paulo 6
Amsterdam 5
Bologna 5
Bonndorf 5
Brescia 5
Campi Bisenzio 5
Casalzuigno 5
Kilburn 5
Reggio Emilia 5
Sacramento 5
Santiago 5
Sydney 5
Bishkek 4
Caserta 4
Totale 9.119
Nome #
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 256
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 242
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 236
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 234
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 225
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 217
Systemic thrombolysis for stroke in pregnancy 212
Torsades de Pointes in patients with polymyalgia rheumatica 204
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 198
Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting 197
Time Course of Corticospinal Excitability and Autonomic Function Interplay during and Following Monopolar tDCS 187
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit 186
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 184
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 181
Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis 180
Delineation of the phenotype associated with 7q36.1q36.2 deletion: long QT syndrome, renal hypoplasia and mental retardation 171
Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review 165
Stroke warning syndrome: 18 new cases 165
Connective tissue diseases and cardiac rhythm disorders: an overview 164
Double ophthalmic arteries arising from the internal carotid artery. A case report of a hidden second ophthalmic artery 162
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 161
Microvascular abnormalities in Rett Syndrome 160
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 159
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 159
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 159
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 158
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxoma 157
Cardiac dysautonomia and serotonin plasma levels in Rett syndrome 156
Neuroimaging and definition of transient ischemic attack 154
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 153
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 151
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 150
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 149
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 148
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 147
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke 147
Cardiac dysautonomia and arterial distensibility in essential hypertensives 146
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 144
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 142
null 141
Sympathetic overactivity and plasma leptin levels in Rett syndrome 139
Autonomic dysfunction in mental retardation and spastic paraparesis with MECP2 mutation. 139
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 138
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 137
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 136
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 135
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 133
Electromagnetic fields produced by incubators influence heart rate variability in newborns 132
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 129
Pharmacogenetics of statins therapy 127
Aortic stiffness in patients with deep and lobar intracerebral hemorrhage: role of antihypertensive drugs and statins: response to letter 127
null 124
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 122
null 122
Sudden death and cardiac arrhythmias in Rett syndrome 122
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 120
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 117
Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome 117
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 114
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 114
Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death? 113
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 112
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 110
Homocysteine and P wave dispersion in patients with heart transplantation 108
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 107
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 105
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 97
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 90
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 85
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 85
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 83
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 79
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 78
Safety of anticoagulation in patients treated with urgent reperfusion for ischemic stroke related to atrial fibrillation 75
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 73
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 72
Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion 71
Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage 71
Acute ischemic stroke and concomitant massive pulmonary embolism: a challenge 71
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 67
null 65
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-associated heart rate-corrected QT interval prolongation 64
Letter regarding “Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis: technical note and case series” 64
Cardiac disease and Rett syndrome 61
null 61
Inflammation and Atrial Electrical Remodelling in Patients With Embolic Strokes of Undetermined Source 61
Autonomic nervous system alterations in Rett syndrome 60
Single-center experience using the 3MAX or 4MAX reperfusion catheter for the treatment of acute ischemic stroke with distal arterial occlusions in patients not eligible for intravenous fibrinolysis 58
Outcome after acute ischemic stroke treatment during Covid-19 outbreak in South-East Tuscany 55
Non-stenosing carotid atherosclerosis and arterial stiffness in embolic stroke of undetermined source 54
Oral anticoagulants in the oldest old with recent stroke and atrial fibrillation 54
Perioperative stroke and hyperhomocysteinemia: A possible pathogenic link 49
To the Editor— Anticoagulation in atrial fibrillation after intracranial hemorrhage: Could the hemorrhage location influence the outcome? 48
Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death 47
Unravelling atrioventricular block risk in inflammatory diseases: systemic inflammation acutely delays atrioventricular conduction via a cytokine-mediated inhibition of connexin43 expression 46
Elevated Interleukin-6 Levels Are Associated With an Increased Risk of QTc Interval Prolongation in a Large Cohort of US Veterans 46
Letter by Acampa et al Regarding Article, "Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage in Patients With a History of Migraine" 45
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 44
Markers of atrial cardiopathy in severe embolic strokes of undetermined source 43
Long-Term Risk of Arterial Thrombosis after Intracerebral Hemorrhage: MUCH-Italy 43
Totale 12.371
Categoria #
all - tutte 49.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.007 0 0 0 0 0 0 212 254 164 197 65 115
2020/20211.786 98 156 78 194 78 170 113 202 255 136 154 152
2021/20221.561 114 157 54 130 78 27 56 154 123 128 226 314
2022/20231.837 114 218 247 233 148 339 72 130 150 60 85 41
2023/20242.013 62 27 158 111 87 499 558 47 34 51 118 261
2024/20251.672 105 185 351 319 424 230 58 0 0 0 0 0
Totale 13.222